After J&J-Synthes Deal, Will Orthopedic Consolidation Hit Zimmer, Stryker?

In the wake of Johnson & Johnson’s $21.3 billion purchase of orthopedic implant maker Synthes, other large ortho firms like Zimmer and Stryker may face growing pressure to make their own acquisitions in order to stay competitive, market watchers speculate.